We are live on
!
Find out more
Creative Planning Portfolio holdings
AUM
$171B
1-Year Est. Return
24.68%
This Fund
S&P 500
This Quarter
Est. Return
-0.2%
1 Year Est. Return
+24.68%
3 Year Est. Return
+62.17%
5 Year Est. Return
+55.89%
10 Year Est. Return
+171.9%
AUM
$147B
AUM Growth
+$7.72B
(+5.5%)
Cap. Flow
+$9.48B
Cap. Flow
% of AUM
6.43%
Top 10 Holdings %
Top 10 Hldgs %
41.95%
Holding
4,221
New
328
Increased
2,776
Reduced
891
Closed
131
Avg Time Held Equity + Options
16.9
quarters
Top 10 Avg Time Held Equity + Options
5.9
quarters
Top 20 Avg Time Held Equity + Options
16.1
quarters
Avg Time Held Equity only
16.9
quarters
Top 10 Avg Time Held Equity only
5.9
quarters
Top 20 Avg Time Held Equity only
16.1
quarters
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Short-Term Bond ETF
BSV
|
+$888M |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$700M |
| 3 |
State Street SPDR Portfolio Developed World ex-US ETF
SPDW
|
+$408M |
| 4 |
iShares Core US Aggregate Bond ETF
AGG
|
+$338M |
| 5 |
Vanguard Russell 1000 Value ETF
VONV
|
+$280M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$248M |
| 2 |
Schwab US Large- Cap ETF
SCHX
|
+$41.4M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$39.9M |
| 4 |
Schwab US Large-Cap Value ETF
SCHV
|
+$34.6M |
| 5 |
Schwab US Mid-Cap ETF
SCHM
|
+$32M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 75.77% |
| 2 | Technology | 8.02% |
| 3 | Financials | 3.7% |
| 4 | Industrials | 2.22% |
| 5 | Healthcare | 2.17% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
3476
Entrada Therapeutics
TRDA
$189M
| $281K | ﹤0.01% |
22,230
+148
| +0.7% | +$1.7K |
2025 Q4
1 quarter
|
|
3477
Atea Pharmaceuticals
AVIR
$399M
| $279K | ﹤0.01% |
51,795
+27,712
| +115% | +$127K |
2024 Q4
5 quarters
|
|
3478
Emergent Biosolutions
EBS
$354M
| $278K | ﹤0.01% |
33,544
+4,996
| +18% | +$51.7K |
2024 Q1
8 quarters
|
|
3479
iShares MSCI Mexico ETF
EWW
$1.44B
| $278K | ﹤0.01% |
3,698
+707
| +24% | +$53.5K |
2025 Q2
3 quarters
|
|
3480
Mechanics Bancorp
MCHB
$3.15B
| $276K | ﹤0.01% |
18,725
+3,896
| +26% | +$57.7K |
2025 Q4
1 quarter
|
|
3481
Invesco S&P Ultra Dividend Revenue ETF
RDIV
$1.41B
| $276K | ﹤0.01% |
4,961
+379
| +8% | +$20.9K |
2023 Q3
10 quarters
|
|
3482
Amplify Etho Climate Leadership US ETF
ETHO
$193M
| $276K | ﹤0.01% |
4,177
| – | – |
2020 Q4
21 quarters
|
|
3483
Diversified Energy Company
DEC
$1.03B
| $276K | ﹤0.01% |
15,820
+511
| +3% | +$7.2K |
2024 Q3
6 quarters
|
|
3484
Invesco Zacks Mid-Cap ETF
CZA
$171M
| $275K | ﹤0.01% |
2,499
-11
| -0.4% | -$1.25K |
2021 Q2
19 quarters
|
|
3485
Vanguard Core Bond ETF
VCRB
$7.59B
| $275K | ﹤0.01% |
+3,548
| New | +$277K |
2026 Q1
0 quarters
|
|
3486
PIMCO Dynamic Income Strategy Fund
PDX
$916M
| $274K | ﹤0.01% |
+12,443
| New | +$252K |
2026 Q1
0 quarters
|
|
3487
Hess Midstream
HESM
$4B
| $274K | ﹤0.01% |
7,051
-2,235
| -24% | -$82.8K |
2024 Q2
7 quarters
|
|
3488
Invesco S&P SmallCap Low Volatility ETF
XSLV
$232M
| $274K | ﹤0.01% |
+5,797
| New | +$280K |
2026 Q1
0 quarters
|
|
3489
BlackRock Health Sciences Trust II
BMEZ
$1.01B
| $273K | ﹤0.01% |
19,024
-315
| -2% | -$4.68K |
2024 Q4
5 quarters
|
|
3490
iShares US Insurance ETF
IAK
$434M
| $273K | ﹤0.01% |
2,129
+20
| +0.9% | +$2.65K |
2024 Q4
5 quarters
|
|
3491
Fossil Group
FOSL
$423M
| $273K | ﹤0.01% |
63,305
+21,983
| +53% | +$88.7K |
2025 Q4
1 quarter
|
|
3492
Northern Trust Ultra-Short Fixed Income ETF
RAVI
$1.6B
| $272K | ﹤0.01% |
3,610
-6,715
| -65% | -$507K |
2025 Q2
3 quarters
|
|
3493
4D Molecular Therapeutics
FDMT
$683M
| $271K | ﹤0.01% |
29,160
-15,035
| -34% | -$131K |
2025 Q3
2 quarters
|
|
3494
State Street SPDR S&P Kensho Clean Power ETF
CNRG
$175M
| $271K | ﹤0.01% |
3,004
+1
| +0% | +$96 |
2025 Q3
2 quarters
|
|
3495
Arbutus Biopharma
ABUS
$814M
| $271K | ﹤0.01% |
60,117
+8,200
| +16% | +$35.9K |
2023 Q4
9 quarters
|
|
3496
iShares Copper and Metals Mining ETF
ICOP
$472M
| $270K | ﹤0.01% |
+5,684
| New | +$287K |
2026 Q1
0 quarters
|
|
3497
CVR Energy
CVI
$6.35B
| $270K | ﹤0.01% |
+8,036
| New | +$207K |
2026 Q1
0 quarters
|
|
3498
Taylor Devices
TAYD
$182M
| $270K | ﹤0.01% |
+4,742
| New | +$365K |
2026 Q1
0 quarters
|
|
3499
iShares Emerging Markets Equity Factor ETF
EMGF
$1.91B
| $270K | ﹤0.01% |
+4,472
| New | +$279K |
2026 Q1
0 quarters
|
|
3500
Ardelyx
ARDX
$806M
| $270K | ﹤0.01% |
45,043
+16,607
| +58% | +$110K |
2024 Q1
8 quarters
|
|
Similar funds
Creative Planning's Q1 2026 Portfolio in Review
As of Q1 2026, Creative Planning held 4,221 positions worth $147B, up 5.5% from $140B the previous quarter. Its ten largest holdings account for 42% of the portfolio.
Creative Planning deployed $9.48B of net new capital in Q1 2026, opening 328 new positions and adding to 2,776 existing holdings. Its largest new stake was Innovator US Equity Power Buffer ETF August: 270,134 shares worth $11.5M.
By sector, the portfolio is most concentrated in Miscellaneous at 76% of assets, down from 76% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Vanguard FTSE Developed Markets ETF, an estimated $248M trimmed.
- Creative Planning's largest Q1 2026 buy was Innovator US Equity Power Buffer ETF August: 270,134 shares worth $11.5M.
- Creative Planning added most to Vanguard Short-Term Bond ETF in Q1 2026, an estimated $888M increase.
- Creative Planning's biggest Q1 2026 reduction was Vanguard FTSE Developed Markets ETF, cutting an estimated $248M.
- Creative Planning fully exited CyberArk in Q1 2026, selling an estimated $9.29M.
- Creative Planning's ten largest holdings make up 42% of its $147B portfolio in Q1 2026.
- Creative Planning opened 328 new positions and closed 131 in Q1 2026.
- Creative Planning's portfolio value rose 5.5% quarter-over-quarter to $147B.
Based on Creative Planning's 13F filing for Q1 2026, filed 12 May 2026.